Viral antichemokines: from pathogenesis to drug discovery
Open Access
- 1 June 2000
- journal article
- editorial
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 105 (11), 1515-1517
- https://doi.org/10.1172/jci10211
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- The viral anti-inflammatory chemokine-binding protein M-T7 reduces intimal hyperplasia after vascular injuryJCI Insight, 2000
- Through the looking glass: the diverse in vivo activities of chemokinesJCI Insight, 1999
- Cytomegalovirus-encoded β chemokine promotes monocyte-associated viremia in the hostProceedings of the National Academy of Sciences of the United States of America, 1999
- CHEMOKINE RECEPTORS AS HIV-1 CORECEPTORS: Roles in Viral Entry, Tropism, and DiseaseAnnual Review of Immunology, 1999
- Role of the Myxoma Virus Soluble CC-Chemokine Inhibitor Glycoprotein, M-T1, during Myxoma Virus PathogenesisVirology, 1999
- Early Murine Cytomegalovirus (MCMV) Infection Induces Liver Natural Killer (NK) Cell Inflammation and Protection Through Macrophage Inflammatory Protein 1α (MIP-1α)–dependent PathwaysThe Journal of Experimental Medicine, 1998
- Virus-Encoded Serine Proteinase Inhibitor SERP-1 Inhibits Atherosclerotic Plaque Development After Balloon AngioplastyCirculation, 1996
- One Step Ahead of the Game: Viral Immunomodulatory MoleculesAnnual Review of Immunology, 1996
- Myxoma Virus M-T7, a Secreted Homolog of the Interferon-γ Receptor, Is a Critical Virulence Factor for the Development of Myxomatosis in European RabbitsVirology, 1996
- Requirement of Mip-1α for an Inflammatory Response to Viral InfectionScience, 1995